TY - JOUR
T1 - Chemotherapy Acute Infusion Reactions
T2 - A Qualitative Report of the Perspectives of Patients With Cancer
AU - Bartlett, David J.
AU - Childs, Daniel S.
AU - Breitkopf, Carmen Radecki
AU - Grudem, Megan E.
AU - Mitchell, Jessica L.
AU - Looker, Sherry A.
AU - Ridgeway, Jennifer L.
AU - Lee, Jennifer L.
AU - Butterfield, Joseph H.
AU - Weroha, S. John
AU - Jatoi, Aminah
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Objective: A growing number of cancer antineoplastic agents can cause life-threatening acute infusion reactions. Because previous studies have not studied these reactions from the perspective of patients, this study was undertaken with that objective in mind. Methods: Patients who had an acute infusion reaction were interviewed based on the Leventhal model. Once saturation of content was achieved, interviews were transcribed and analyzed with qualitative methodology. Results: Twenty-one patients were enrolled. Most were women (n = 15); the median age was 58 years, and paclitaxel was the most common inciting agent. Three themes emerged. First, these reactions are frightening; patients made remarks such as “I was just thinking oh my God, I am dying.” Second, prior education about these reactions seemed to mitigate this fear, “Basically everything the nurses told me potentially could happen, like happened. So, I was prepared.” Third, when health-care providers were prompt and attentive during the reaction, patients described less fear with future chemotherapy, “So no, I’m really not fearful about going in tomorrow because I know they’ll be there and they’ll be watching me.” Conclusion: These reactions evoke fear which can be mitigated with education prior to and with prompt responsiveness during the acute infusion reaction.
AB - Objective: A growing number of cancer antineoplastic agents can cause life-threatening acute infusion reactions. Because previous studies have not studied these reactions from the perspective of patients, this study was undertaken with that objective in mind. Methods: Patients who had an acute infusion reaction were interviewed based on the Leventhal model. Once saturation of content was achieved, interviews were transcribed and analyzed with qualitative methodology. Results: Twenty-one patients were enrolled. Most were women (n = 15); the median age was 58 years, and paclitaxel was the most common inciting agent. Three themes emerged. First, these reactions are frightening; patients made remarks such as “I was just thinking oh my God, I am dying.” Second, prior education about these reactions seemed to mitigate this fear, “Basically everything the nurses told me potentially could happen, like happened. So, I was prepared.” Third, when health-care providers were prompt and attentive during the reaction, patients described less fear with future chemotherapy, “So no, I’m really not fearful about going in tomorrow because I know they’ll be there and they’ll be watching me.” Conclusion: These reactions evoke fear which can be mitigated with education prior to and with prompt responsiveness during the acute infusion reaction.
KW - carboplatin
KW - education
KW - infusion reactions
KW - oxaliplatin
KW - paclitaxel
KW - qualitative
UR - http://www.scopus.com/inward/record.url?scp=85046722287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046722287&partnerID=8YFLogxK
U2 - 10.1177/1049909118773995
DO - 10.1177/1049909118773995
M3 - Article
C2 - 29724109
AN - SCOPUS:85046722287
SN - 1049-9091
JO - American Journal of Hospice and Palliative Medicine
JF - American Journal of Hospice and Palliative Medicine
ER -